Papers

8

Total Citations

321

H-Index

8

About

No biography available yet.

Research Focus

Key Achievements

8
H-Index
8
Papers
321
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
94 citations · 2022
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 54
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Not generated yet